A Study Evaluating the Safety, Tolerance and Anti-tumor Activity of a Study Drug in Subjects With Advanced Solid Tumors
Clinical trial NCT04135261 · COMPLETED
Trial details
- NCT number
- NCT04135261
- Sponsor
- Harbour BioMed US, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-24
- Primary completion
- 2023-01-17
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.